| Renal Cell Carcinoma |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| Antineoplastic Drug |
0 |
0.8 |
| Kidney Cancer |
0 |
0.67 |
| Cancer |
0 |
0.59 |
| Toxicology |
0 |
0.57 |
| Tyrosine Kinase Inhibitor |
0 |
0.54 |
| Vascular Endothelial Growth Factor |
0 |
0.51 |
| VEGF Inhibitor |
0 |
0.41 |
| Tumor |
0 |
0.22 |
| Clinical Research |
0 |
0.15 |
| Receptors |
0 |
0.15 |
| Healthcare and Medical Technology |
0 |
0.14 |
| Humanized Monoclonal Antibody |
0 |
0.13 |
| Angiogenesis Inhibitors |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Glucocorticoid |
0 |
0.07 |
| Immunotherapy |
0 |
0.07 |
| Medical Oncology |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |
| mTOR Inhibitor |
0 |
0.07 |
| Tyrosine Kinase |
0 |
0.07 |